EVO

Dopo l'orario di chiusura: 5.55

Evotec Se Adr (EVO)

Panoramica Notizia Cronologia dei prezzi Perché EVO Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Evotec Se Adr Stock (EVO) Company Profile

Evotec Se Adr

Healthcare (1196)

Prossima data di guadagno

Ultimi documenti SEC

EVO's Discussions on Twitter

Confronta EVO con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
EVO	5.55	2.00B	853.32M	-184.46M	-264.08M	-0.3415
ZTS	176.42	79.51B	9.15B	2.43B	2.31B	4.92
TAK	13.53	42.89B	30.27B	1.93B	3.45B	0.444
HLN	9.43	42.57B	14.26B	1.55B	0	0.3327
TEVA	16.49	18.51B	16.77B	-959.00M	1.37B	-2.00
VTRS	13.00	15.37B	15.24B	-646.50M	1.88B	1.53

Evotec Se Adr Stock (EVO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-01-18	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2023-06-23	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2023-06-16	Downgrade	BofA Securities	Buy → Neutral
2023-06-08	Aggiornamento	Citigroup	Neutral → Buy
2023-04-04	Aggiornamento	Morgan Stanley	Underweight → Equal-Weight
2022-12-09	Iniziato	H.C. Wainwright	Buy
2022-11-16	Downgrade	Deutsche Bank	Buy → Hold
2022-08-10	Downgrade	Morgan Stanley	Overweight → Underweight
2022-03-02	Ripresa	Cowen	Outperform
2022-01-07	Ripresa	Citigroup	Neutral

Mostra tutto

Evotec Se Adr Borsa (EVO) Ultime notizie

Evotec Se Adr Azioni (EVO) Dati Finanziari

Evotec Se Adr (EVO)

Evotec Se Adr Stock (EVO) Company Profile

Confronta EVO con altri titoli

Evotec Se Adr Stock (EVO) Upgrades & Downgrades

Evotec Se Adr Borsa (EVO) Ultime notizie

Halozyme outlines plan to acquire Evotec for €2 billion By Investing.com - Investing.com UK

Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid - MSN

Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion - AOL

Evotec SE responds to media speculation - Investing.com

Halozyme Therapeutics sinks after confirming $2B Evotec buyout offer - Seeking Alpha

Evotec SE responds to media speculation By Investing.com - Investing.com UK

Halozyme proposes $2 billion acquisition of Evotec - Investing.com India

Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal - Benzinga

Earnings call: Evotec SE maintains 2024 outlook amid strategic changes - Investing.com India

Evotec SE ADR earnings beat by $0.02, revenue fell short of estimates - Investing.com

Evotec Reports Strategic Growth Amidst Revenue Challenges - TipRanks

Stock Information - Evotec

Annual General Meeting - Evotec

Investor Relations - Evotec

Earnings call: Evotec SE reports revenue increase, plans cost cuts - Investing.com

Earnings call: Evotec SE revises 2024 outlook amid market challenges By Investing.com - Investing.com Canada

Earnings call: Evotec SE revises 2024 outlook amid market challenges - Investing.com

Evotec SE Reports H1 2024 Results: Challenging Year; Priority Reset for Sustainable Profitable Growth Gaining Momentum, Building on Core Strengths - Yahoo Finance

Dozens of US Stocks Are Newly Undervalued After Market Selloff - Morningstar

Evotec Faces Short-Term Headwinds and Rising Costs, but Long-Term Growth Outlook Remains Positive - Morningstar

Evotec shares crash 36% on profit warning - Investing.com

Antibody Discovery Market Size Expected to Surge to USD 4.8 - GlobeNewswire Inc.

Evotec stock holds Buy rating with price target from TD Cowen By Investing.com - Investing.com India

Evotec (OTCMKTS:EVTCY) Sets New 52-Week Low at $4.65 - Defense World

Financial Metrics Check: Evotec SE ADR (EVO)'s Ratios for Trailing Twelve Months – DWinneX - The Dwinnex

Healthcare Sector - Morningstar

Ratio Examination: Evotec SE ADR (EVO)'s Price-to-Cash and Price-to-Free Cash Flow – DWinneX - The Dwinnex

Evotec's Underlying Demand Looks Stable as Momentum Builds, but Some Market Challenges Linger - Morningstar

Earnings call: Evotec SE Q1 2024 results show mixed performance amid challenges - Investing.com South Africa

Earnings call: Evotec SE Q1 2024 results show mixed performance amid challenges By Investing.com - Investing.com

Evotec gains R&D license from Centogene for Gaucher disease - Investing.com India

Closing Bell Recap: Evotec SE ADR (EVO) Ends at 5.23, Reflecting a -31.63 Downturn – DWinneX - The Dwinnex

QT to end this December with hardly a whimper: Barclays By Investing.com - Investing.com

Dow Dips Over 100 Points; Ribbon Communications Shares Spike Higher By Benzinga - Investing.com UK

Evotec and Variant Bio partner to develop fibrosis treatments By Investing.com - Investing.com

T. Rowe Price Raises Stake in Evotec SE - TipRanks

Germany stocks mixed at close of trade; DAX down 0.03% By Investing.com - Investing.com

Germany stocks mixed at close of trade; DAX down 0.30% By Investing.com - Investing.com

Evotec: R&D, Customer Growth Not Enough To Offset Headwinds - Seeking Alpha

Stocks Climb Before the Open as Investors Weigh Economic Outlook, U.S. JOLTs Report in Focus - The Globe and Mail

Evotec (EVO) Inks Drug Discovery Collaboration Deal With J&J - Yahoo Finance

Evotec SEADR Shares Near 52-Week LowMarket Mover - Nasdaq

A Peek Into The Markets: US Stock Futures Rise; J&J Secures Emergency Authorization for Covid-19 Vaccine - Benzinga

Evotec (EVTCY) Presents At Jefferies 2017 London Healthcare ConferenceSlideshow (NASDAQ:EVO) - Seeking Alpha

Together for Medicines That MatterEvotec Website (English) - Evotec

Evotech and Roche subsidiary Genentech enter into drug discovery alliance - Proactive Investors USA

Evotec Se Adr Azioni (EVO) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a EVO